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Abstract
Background
Vietnam is a lower middle-income country with no national surveillance system for hospital-
acquired infections (HAIs). We assessed the prevalence of hospital-acquired infections and
antimicrobial use in adult intensive care units (ICUs) across Vietnam.
Methods
Monthly repeated point prevalence surveys were systematically conducted to assess HAI
prevalence and antimicrobial use in 15 adult ICUs across Vietnam. Adults admitted to par-
ticipating ICUs before 08:00 a.m. on the survey day were included.
Results
Among 3287 patients enrolled, the HAI prevalence was 29.5% (965/3266 patients, 21 miss-
ing). Pneumonia accounted for 79.4% (804/1012) of HAIs Most HAIs (84.5% [855/1012])
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were acquired in the survey hospital with 42.5% (363/855) acquired prior to ICU admission
and 57.5% (492/855) developed during ICU admission. In multivariate analysis, the stron-
gest risk factors for HAI acquired in ICU were: intubation (OR 2.76), urinary catheter (OR
2.12), no involvement of a family member in patient care (OR 1.94), and surgery after
admission (OR 1.66). 726 bacterial isolates were cultured from 622/1012 HAIs, most fre-
quently Acinetobacter baumannii (177/726 [24.4%]), Pseudomonas aeruginosa (100/726
[13.8%]), and Klebsiella pneumoniae (84/726 [11.6%]), with carbapenem resistance rates
of 89.2%, 55.7%, and 14.9% respectively. Antimicrobials were prescribed for 84.8% (2787/
3287) patients, with 73.7% of patients receiving two or more. The most common antimicro-
bial groups were third generation cephalosporins, fluoroquinolones, and carbapenems
(20.1%, 19.4%, and 14.1% of total antimicrobials, respectively).
Conclusion
A high prevalence of HAIs was observed, mainly caused by Gram-negative bacteria with
high carbapenem resistance rates. This in combination with a high rate of antimicrobial use
illustrates the urgent need to improve rational antimicrobial use and infection control efforts.
Introduction
Hospital-acquired infections (HAIs) and antimicrobial resistance are growing global public
health problems [1,2]. The incidence of HAIs is substantially higher in Low and Middle
Income Countries (LMICs), with an average prevalence of 15.5%, compared to prevalence of
7.1% and 4.5% in Europe and USA, respectively [3]. This problem is more serious in intensive
care units (ICUs). The HAI prevalence in ICUs ranges from 9.1% in the United States to about
23.0%-23.5% in Europe and England [4–7], and even higher in LMICs with a pooled preva-
lence of 35.2% [1]. A recent report of the International Nosocomial Infection Control Consor-
tium 2007–2012 from 503 ICUs shows that ventilator-associated pneumonia is fifteen times
and catheter-associated urinary tract infection four times higher in LMICs than in better
resourced settings [8]. Due to economic development in LMICs, the healthcare systems are
changing rapidly, with increasing ICU capacities. However resource constraints often result in
high occupancy rates, crowding, a lack of isolation facilities, and insufficient resources for ade-
quate infection control all of which may contribute to the reported high incidence of HAIs and
drug-resistant infections at ICU’s in these settings [1,9,10].
Vietnam is a LMIC with a population of 90.796 million [11] and an increasingly sophisti-
cated health care system, typical of countries in the region. Health expenditure per capita in
Vietnam was around 100$ per annum in 2012, approximately a seventh of the regional average
[11]. Up to now, there is no national surveillance system for HAIs and limited data about HAIs
in ICUs. The few studies performed are small and only some include ICUs, but reported that
the HAI prevalence in those ICUs ranged from 19.3% to 31.3% [12–17]. Only one of these
studies is from the international peer reviewed literature [12], the others are published in the
Vietnamese medical literature. Antimicrobial resistance levels are high in Vietnam; up to 70%
of Enterobacteriaceae were resistant to 3rd generation cephalosporins and> 40.0% of Acineto-
bacter spp. resistant to carbapenems in 2009 [9,18].
In order to provide up-to-date, systematic data and to demonstrate the feasibility of devel-
oping a national surveillance network for ICUs in a LMIC, we performed a prospective study
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on the prevalence of HAI in ICUs across Vietnam, exploring risk factors, antimicrobial use,
and antimicrobial resistance [19].
Materials and Methods
Study design, hospital and patient selection
We conducted a repeated point prevalence survey (PPS) to determine the prevalence of HAIs,
and to assess antimicrobial use and antimicrobial resistance using the methodology developed
by the European Center for Disease Prevention and Control (ECDC) [20]. The survey was con-
ducted on one day each month from October 2012 through September 2013 in 15 adult ICUs
in 14 acute care hospitals, of which 7 were tertiary hospitals and 7 provincial hospitals,
throughout Vietnam (Fig 1). Patients aged 18 years, admitted to participating ICUs before 8
a.m. on the survey day, and remaining there at the survey time were included regardless after
that time patient was discharged or remain in that ICU.
Data collection
The following patient data were collected: reason for admission, location of patient at admis-
sion to ICU, comorbidity, current interventions, involvement of patient’s family in patient care
(participating in bathing, cleaning, changing position, and feeding patients), antimicrobial
agent use for any indication, presence of HAI according to ECDC definitions [20], and results
of routine microbiological investigations.
All participating hospitals provided data on basic infrastructure and infection control indi-
cators at the beginning of the study, including total number of beds, rooms, single bed rooms,
number of doctors and nurses at the ICUs, admissions per year, patient days per year, alcohol
hand rub consumption, and availability of alcohol hand rub at ICU bed.
All participating hospital laboratories were trained to follow the Clinical and Laboratory Stan-
dards Institute guidelines (CLSI) for antimicrobial susceptibility testing and were enrolled in an
external quality assurance program (The United Kingdom National External Quality Assessment
Service (UK NEQAS) for Microbiology) [19]. All participating doctors received training on the
protocol, HAI definitions, how to complete case record forms, and data entry before the study. A
database adapted fromHELICSWin.Net developed by the ECDC was used for the study [21].
Each ICU received a laptop with the software installed and Vietnamese instructions. The anon-
ymised data were submitted to the project coordinators electronically once a month during the
implementation period. Data were then checked for missing or inconsistent data, with regular
queries sent to the hospitals and visits by study investigators to assist in data reconciliation.
Statistical analysis
For descriptive statistics we calculated percentage, frequency, mean, and median values and
95% confidence interval (95% CI) or interquartile ranges (IQR), as appropriate. Where patients
were included in more than one PPS, we only used the data from the first survey and had no
HAI at ICU admission to calculate the odds ratios of risk factors for developing HAIs in ICU.
After univariate analysis, we included all HAI risk factors in the multivariate logistic regression
models. We used IBM SPSS Statistics software (version 22 IBM, California, USA) for data anal-
ysis. P-values< 0.05 (two-sided) were considered statistically significant.
Ethical considerations
The Ethical Committee of the National Hospital for Tropical Diseases (27/HDDD-NHTD)
had approved of the study and confirmed that the need for informed consent was waived due
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Fig 1. The Study Site Locations.
doi:10.1371/journal.pone.0147544.g001
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to data were anonymous and collected by surveillance and no intervention was conducted; and
the study was also approved by the Vietnamese Ministry of Health (4921/QD-BYT).
Results
Hospital and ICU resources
Hospital sizes ranged from 280 to 2362 beds (median 950; IQR 750–1650) and the participating
ICU sizes ranged from 10 to 60 beds (median 20; IQR 18–31). Mean length of ICU stays per
individual ICU ranged from 3.8 to 16.0 days with a median mean length of stay across the
ICUs of 6.4 days (IQR: 4.8–9.3). There were no national antimicrobial therapy guidelines, but
locally derived guidelines were used at 7 of 15 ICUs. In each ICU one nurse took care of 1.9 to
5.9 beds (median 3.6, IQR 3.1–4.4 beds) per 8 hours shift. During working hours, there was a
median of 3.5 doctors (IQR: 2.5–4.8) for 10 ICU beds. Alcohol hand rub was available at the
bedside in all participating ICUs. Median alcohol hand rub consumption per patient day was
66.4 ml (IQR: 23.7–100.5). More details are presented in Table A in S1 File.
Patient characteristics
In total, 3,401 patients were screened, of whom 3287 (114 were excluded due to age< 18 years)
were enrolled from 15 ICUs of 14 participating hospitals between October 2012 and October
2013. Due to prolonged ICU stay, 162 patients were enrolled in more than one survey leaving
3125 unique patients.
The median age was 61.0 years (IQR 45.0–77.0) and 63.9% (2101/3287) of patients were
male. Most patients (46.2%; 1427/3088; 199 missing) were admitted directly from the commu-
nity, while 30.1% (930/3088) of the patients entered the ICU from another department in the
same hospital and 20.7% (638/3088) were referred from other hospitals. 52.3% (1719/3287)
patients were intubated, 28.0% (921/3287) had a central vascular catheter, 49.2% (1616/3287)
had a urinary catheter, and 8.2% (270/3287) were on renal replacement therapy. In 63.0%
(2072/3287) of patients, family members were involved in patient care. Details are presented in
Table B in S1 File.
Comorbidity was present in 39.6% of patients (1249/3151, 136 missing), of which 190
patients had two or more comorbidities. Common comorbidities were: stroke sequelae 27.5%
(343/1249), diabetes mellitus 24.8% (310/1249), chronic obstructive pulmonary disease 20.7%
(259/1249), renal failure 11.5% (144/1249), harmful alcohol use 11.3% (141/1249), active
malignancy 9.5% (119/1249), and induced immunosuppression 6.1% (76/1249).
HAI prevalence
Overall, 29.5% (965/3266 patients, 21 missing) had at least one HAI; 922 patients had one
HAI, 39 patients had 2 HAIs, and 4 patients had 3 HAIs. The HAI prevalence ranged widely
between ICUs from 5.6% to 60.9% with a median prevalence of 30.5% (Table B in S1 File).
Prevalence of HAI per month in year fluctuated from 23.8% in April to 34.8% in November,
prominent in March (34.1%), July (33.4%), November (34.8%), and December (34.7%)
(Table C in S1 File). Pneumonia was the most common HAI (79.4% [804/1012]), followed by
blood stream infection (4.4% [44/1012]), and surgical site infections (4.2% [42/1012]). Most
HAIs (84.5% [855/1012]) were acquired in the survey hospital: 42.5% (363/855) acquired prior
to ICU admission and 57.5% (492/855) developed after ICU admission. The median time from
hospital admission to diagnosis of HAI was 7 days (IQR: 3–15 days). Device-associated HAIs
accounted for 643/1012 (63.5%) of HAIs, mainly pneumonia (589/643 [91.6% of device-associ-
ated HAIs]) (Table 1).
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Risk factors for HAIs Acquired in ICU
We assessed risk factors for ICU-acquired HAIs in 2,618 patients who were enrolled in the
study for the first time and had no HAI at ICU admission. The prevalence of HAI among
these patients at survey time was 16.2% (424/2618 patients). In the univariate analysis,
exception for gender, age group, and comorbidity, all other factors had risk for HAI with
statistically significant. The highest risk factors were intubation (OR 6.31 [95% CI 4.86–
8.18]), having surgery after admission (minor surgery OR 4.78 [95% CI 3.57–6.40], major
surgery OR 3.78 [95% CI 2.90–4.93]), and urinary catheter (OR 3.90 [95% CI 3.09–4.92])
(Table 2).
Multivariate logistic regression identified eight risk factors independently associated
with HAIs, which included: intubation (OR 2.76 [95% CI 2.03–3.75]), urinary catheter (OR
2.12 [95% CI 1.57–2.87]), no involvement of a family member in patient care (OR 1.94
[95% CI 1.49–2.51]), surgery after admission (minor surgery OR 1.67 [95% CI 1.16–2.41],
major surgery OR 1.66 [95% CI 1.06–2.58]), admission to ICU from the same hospital OR
1.49 [95% CI 1.09–2.04]), central vascular catheter (OR 1.47 [95% CI 1.05–2.06]), periph-
eral vascular catheter showed a protective effect in univariate analysis but was associated
with a significant increased risk for HAIs in multivariate analysis (OR 1.47 [95% CI 1.02–
2.12]), and every one day longer of ICU stay (OR 1.08 [95% CI 1.07–1.10]) (Table 2).
Table 1. Location of Acquired HAI and Association with Invasive Devices.
Type of infections Location Acquired HAI Related device Total No. of HAI, n
(%)
Current hospital Other
hospital
UNK Yes No UNK
In ICU Out ICU
Pneumonia & LRTIa, n (%) 389
(48.4)
301
(37.4)
60 (7.5) 54
(6.7)
589
(73.3)
120
(14.9)
95 (11.8) 804 (79.4)
Bloodstream infection, n (%) 34 (77.3) 8 (18.2) 2 (4.5) 0 27 (61.4) 11 (25.0) 6 (13.6) 44 (4.4)
Surgical site infection, n (%) 23 (54.8) 11 (26.2) 6 (14.3) 2 (4.8) NA NA NA 42 (4.2)
Gastrointestinal infection, n (%) 13 (32.5) 19 (47.5) 7 (17.5) 1 (2.5) NA NA NA 40 (4.0)
Urinary tract infection, n (%) 18 (62.1) 8 (27.6) 3 (10.3) 0 27 (93.1) 2 (6.9) 0 29 (2.9)
Central nervous system infection, n
(%)
5 (26.3) 4 (21.1) 8 (42.1) 2
(10.5)
NA NA NA 19 (1.9)
Skin and soft tissue infection, n (%) 2 (13.3) 6 (40.0) 1 (6.7) 6
(40.0)
NA NA NA 15 (1.5)
Other infectionsb, n (%) 8 (42.1) 6 (31.6) 2 (10.5) 3
(15.8)
NA NA NA 19 (1.9)
Total, n (%) 492
(48.6)
363
(35.9)
89 (8.8) 68
(6.7)
643
(63.5)
133
(13.1)
101
(10.0)
1012 (100)
UNK: unknown or missing data
NA: Not applicable
LRTI: low respiratory tract infection
a Only one case of LRTI
b Including: nine cases of systemic infection, four catheter related infections, four reproductive tract infections, one endocarditis and one eyes ear nose
throats infection not classiﬁed.
Note: Twenty-one patients whose infection could not be differentiated between community-acquired and hospital-acquired infection were excluded from
calculating HAI prevalence.
doi:10.1371/journal.pone.0147544.t001
Hospital Acquired Infection in Vietnamese Intensive Care Units
PLOS ONE | DOI:10.1371/journal.pone.0147544 January 29, 2016 6 / 15
Table 2. Risk Factors for Acquiring HAI in ICU.
Risk factors No. of patients
(total = 2618), n
Patients with HAI
(total = 424), n (%)
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Gender
Male 1656 271 (16.4) 1.03 (0.83–
1.28)
0.758 1.22 (0.94–
1.59)
0.137
Female 962 153 (15.9) Reference Reference
Missing 0 141
Age group
18–60 years 1344 202 (15.0) Reference Reference
> 60 years 1274 222 (17.4) 1.19 (0.97–
1.47)
0.097 1.17 (0.90–
1.52)
0.233
Missing 0 141
Location of patients at admission to
ICU
Community and others 1352 144 (10.7) Reference Reference
Same hospital 655 171 (26.1) 2.96 (2.32–
3.79)
< 0.001 1.49 (1.09–
2.04)
0.013
Other hospital 507 109 (21.5) 2.30 (1.75–
3.02)
< 0.001 1.23 (0.87–
1.72)
0.239
Missing 104 141
Reason for admission
Medical disease 1029 120 (11.7) Reference Reference
Infectious disease 1106 214 (19.3) 1.82 (1.43–
2.31)
< 0.001 0.91 (0.67–
1.23)
0.536
Surgery 368 90 (24.5) 2.45 (1.81–
3.32)
< 0.001 0.73 (0.45–
1.19)
0.214
Missing 115 141
Comorbidity
No comorbidity 1560 250 (16.0) Reference Reference
Have comorbidity 972 171 (17.6) 1.12 (0.90–
1.38)
0.303 0.90 (0.70–
1.17)
0.445
Missing 86 141
Surgery after admission
Non surgery 2009 219 (10.9) Reference Reference
Minor surgery 252 93 (36.9) 4.78 (3.57–
6.40)
< 0.001 1.67 (1.16–
2.41)
0.005
Major surgery 354 112 (31.6) 3.78 (2.90–
4.93)
< 0.001 1.66 (1.06–
2.58)
0.025
Missing 3 141
Intubation
Yes 1252 346 (27.6) 6.31 (4.86–
8.18)
< 0.001 2.76 (2.03–
3.75)
< 0.001
No 1366 78 (5.7) Reference Reference
Missing 0 141
Central vascular catheter
Yes 693 197 (28.4) 2.97 (2.39–
3.68)
< 0.001 1.47 (1.05–
2.06)
0.026
No 1925 227 (11.8) Reference Reference
Missing 0 141
Urinary catheter
(Continued)
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Microbiological Aetiology of HAIs
From 593/965 (61.5%) patients with HAI, 726 microorganisms were reported in association
with 622 HAIs. For 390 HAIs in 372 patients no pathogens were isolated. All reported path-
ogens are summarized in Table 3. Antimicrobial resistance to frequently used antimicrobi-
als was common. Carbapenem resistance was most common in Acinetobacter baumannii
(89.2% [149/167]) and Pseudomonas aeruginosa (55.7% [49/88]). Slightly over 5% of the
Enterobacteriaceae isolated were carbapenem resistant, while 14.9% (11/74) Klebsiella
pneumonia were carbapenem resistant. More than 75% of the Staphylococcus aureus isolates
were methicillin resistant and more than 57% of the Enterococci were resistant to
glycopeptides.
Table 2. (Continued)
Risk factors No. of patients
(total = 2618), n
Patients with HAI
(total = 424), n (%)
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Yes 1226 312 (25.4) 3.90 (3.09–
4.92)
< 0.001 2.12 (1.57–
2.87)
< 0.001
No 1392 112 (8.0) Reference Reference
Missing 0 141
Hemodialysis
Yes 203 51 (25.1) 1.84 (1.31–
2.57)
< 0.001 1.34 (0.87–
2.08)
0.188
No 2415 373 (15.4) Reference Reference
Missing 0 141
Peripheral vascular catheter
Yes 2202 321 (14.6) 0.52 (0.40–
0.67)
< 0.001 1.47 (1.02–
2.12)
0.037
No 416 103 (24.8) Reference Reference
Missing 0 141
Family involved patient care
Yes 1717 190 (11.1) Reference Reference
No 901 234 (26.0) 2.82 (2.28–
3.48)
< 0.001 1.94 (1.49–
2.51)
< 0.001
Missing 0 141
Each day longer from ICU admission
to survey time
In analysis 2513 424 (16.9) 1.08 (1.07–
1.10)
< 0.001 1.08 (1.07–
1.10)
< 0.001
Missing 105 141
For multivariate regression analysis:
• Omnibus test of model coefﬁcients: -2 Log likelihood 1720.120, Chi-square (538.055, df 16, p < 0.001)
• Nagelkerke R-Square: 0.326
• Hosmer & Lemeshow test (Chi-square 10.592, df 8, p = 0.226)
• Classiﬁcation accuracy: 85.3% (97.0% for no HAI, 28.0% for HAI, with cut value is 0.50).
doi:10.1371/journal.pone.0147544.t002
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Antimicrobial use
Antimicrobials use was evaluated in all enrolled patients. The proportion of patients receiv-
ing antimicrobials at survey time ranged from 50.0% to 99.8% per ICU, with a pooled pro-
portion of 84.8% (2787/3287). 733 (22.3%) patients were prescribed one, 1343 (40.8%) two,
552 (16.8%) three, and 159 (4.8%) four antimicrobial agents. The main indications for anti-
microbial use were community-acquired infections 41.8% (2386/5711) and HAIs 33.9%
(1937/5711). As infectious diseases are common in Vietnam, having a severe community-
acquired infection was a common reason for admission to an ICU. Prophylaxis and other
use were the indications for antimicrobial use in 9.4% (536/5711) and the indication was
unknown in 14.9% (852/5711).
Table 3. Microorganisms Causing HAIs.
Name of
Microorganisms
All pathogen
isolated
(total = 726) n (%)
Pathogen for
pneumonia
(total = 587) n (%)
Pathogen for blood
stream infections
(total = 44) n (%)
Pathogen for surgical
site infections
(total = 34) n (%)
Pathogen for urinary
tract infections
(total = 25) n (%)
Gram-negative
bacteria
611 (84.2) 516 (87.9) 28 (63.6) 25 (73.5) 15 (60.0)
Acinetobacter
baumannii
177 (24.4) 151 (25.7) 10 (22.7) 2 (5.9) 5 (20.0)
Pseudomonas
aeruginosa
100 (13.8) 92 (15.7) 2 (4.5) 3 (8.8) 0
Klebsiella pneumoniae 84 (11.6) 68 (11.6) 5 (11.4) 8 (23.5) 1 (4.0)
Acinetobacter spp. 46 (6.3) 46 (7.8) 0 0 0
Escherichia coli 39 (5.4) 20 (3.4) 6 (13.6) 4 (11.8) 3 (12.0)
Enterobacteriaceae 36 (5.0) 26 (4.4) 1 (2.3) 2 (5.9) 5 (20.0)
Klebsiella spp. 35 (4.8) 26 (4.4) 2 (4.5) 2 (5.9) 1 (4.0)
Providencia spp. 28 (3.9) 25 (4.3) 0 2 (5.9) 0
Klebsiella oxytoca 19 (2.6) 18 (3.1) 0 1 (2.9) 0
Achromobacter spp. 18 (2.5) 17 (2.9) 0 1 (2.9) 0
Stenotrophomonas
maltophilia
6 (0.8) 6 (1.0) 0 0 0
Gram-negative bacilli
others
18 (2.5) 17 (2.9) 1 (2.3) 0 0
Gram-negative cocci
other
4 (0.6) 4 (0.7) 0 0 0
Anaerobic bacilli 1 (0.1) 0 1 (2.3) 0 0
Gram-positive
bacteria
104 (14.3) 65 (11.1) 15 (34.1) 9 (26.5) 7 (28.0)
Staphylococcus
aureus
39 (5.4) 28 (4.8) 6 (13.6) 3 (8.8) 0
Staphylococcus spp. 19 (2.6) 11 (1.9) 6 (13.6) 0 1 (4.0)
Streptococcus spp. 11 (1.5) 9 (1.5) 0 1 (2.9) 0
Enterococcus spp. 16 (2.2) 9 (1.5) 2 (4.5) 1 (2.9) 2 (8.0)
Enterococcus faecalis 8 (1.1) 2 (0.3) 1 (2.3) 3 (8.8) 2 (8.0)
Enterococcus faecium 5 (0.7) 0 0 1 (2.9) 2 (8.0)
Gram-positive bacilli
other
6 (0.8) 6 (1.0) 0 0 0
Fungi 11 (1.5) 6 (1.0) 1 (2.3) 0 3 (12.0)
Candida spp. 10 (1.4) 5 (0.8) 1 (2.3) 0 3 (12.0)
Other fungi 1 (0.1) 1 (0.2) 0 0 0
doi:10.1371/journal.pone.0147544.t003
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Antimicrobials for systemic use (ATC group J01) accounted for 97.9% (5590/5711) of the
total antimicrobials used. Of which, third generation cephalosporins, fluoroquinolones, and car-
bapenems were used most common—accounting for 20.1% (1126/5590), 19.4% (1082/5590),
and 14.1% (786/5590), respectively. For the treatment of HAIs, the most frequently used agents
were carbapenems at 22.9% (432/1890), fluoroquinolones 16.0% (302/1890), and 3rd generation
cephalosporins 15.5% (293/1890). Polymyxins (parenteral colistin) accounted for 3.3% (186/
5590) of general use but were the fifth most frequently used agent for HAIs; (Fig 2). For HAIs
associated with carbapenem resistant A. baumannii and P. aeruginosa, colistin was given to
65.1% (97/149) and 30.6% (15/49), respectively. More details in Tables D and E in S1 File.
Fig 2. Antimicrobials for Systemic Use by Indication. CAIs: Community acquired infections; HAIs: Hospital-acquired infections; Prophylaxis: Medical and
surgical prophylaxis; others: other indications (e.g. erythromycin use for prokinetic) and unknown indication.
doi:10.1371/journal.pone.0147544.g002
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Discussion
The HAI prevalence in this study (29.5%, 965/3266 patients) is higher than that reported from
adult ICUs in European hospitals using the same protocol (23.0%, 1750/7613 patients) [5] and in
ICUs in Southern Europe, Turkey and Iran (23.5%, 176/749 patients) [7] and much higher than
rate of 9.1% (156/1707) in ICUs in the United States in 2011[4]. These differences can be explained
by several factors: There were few single rooms in ICUs and common rooms usually contain 4–5
beds and even up to 30 beds; In addition with low healthcare staff ratios [11] and high bed occu-
pancy rates [22], often over 110%, makes successful infection control very challenging. The lack of
nursing staff for patient care allows little time for proper infection control measures, which may
lead to an increased HAI rate [23–25]. This is supported by the smaller amount of alcohol hand
rub used: a median of 66.4 ml (IQR: 23.7–100.5 ml)/patient day, compared with a median of 83 ml
(IQR: 64–105)/patient day in ICUs of Germany in 2010 [26]. However, the HAI prevalence in
Vietnamese ICUs was lower than the pooled prevalence of 35.2% in other LMICs [3].
Hospital-acquired pneumonia (HAP) was the most common type of HAI as in other studies
[1,3,7]. HAP accounted for 79.4% of all HAIs in our study, nearly double that reported (40.0%
- 45.3%) in ICUs of developed countries [5,6]. This is due to a large proportion of HAP (37.4%,
301/804) was acquired in the same hospital before admission to ICU. This figure raises the
need for effective infection control program outside ICU for HAP prevention. Blood stream
infections (BSI) accounted for 4.4% of all HAI, considerable lower than the reported 18.0% in
European ICUs [5]. Potentially this is due to the high HAP prevalence, but there might also be
an underestimation of BSI due to underutilization of blood cultures; as an indication there
were a total of only 243 blood culture samples taken from the 3287 patients in the 24 hour pre-
ceding the survey day, we are not aware of any comparable data from other settings.
Multivariate analysis identified intubation as an important risk factor, which combined with
the high prevalence of HAP suggests that future interventions should target this risk factor.
Potential interventions to assess include ventilation and sedation strategies, cuff and tracheal
tube design, cuff pressure management [27] Strategies like selective gut decontamination using
polymyxins may not be appropriate in this setting with high antimicrobial resistance background
rates with colistin as last resort drug [28]. Multivariate analysis revealed that the involvement of
the patient’s family in patient care was a protective factor fromHAI. As ICUs had department-
wide policies to either allow or forbid family from taking care of their admitted family member
this practice was highly clustered at the ICU level, the result needs to be interpreted with caution.
Further research is needed to understand the risks for HAI regarding family members involved
in patient care. National surveillance systems for HAI are scarce in LMIC settings yet ongoing
surveillance is crucial to informing policymakers of the needs of the population and high quality
data is critical to the development of potential interventions applicable at the national level.
The proportion of HAIs related to medical devices were higher than that reported by a
European survey in 2011–2012, where device related HAIs were 59.5% for UTI, 57.3% for pri-
mary BSI, and 33.2% for HAP [5]. This may be partly explained by less compliance with hand
hygiene [25] and low alcohol hand rub consumption, but probably also sub-optimal routines
for insertion and care of urinary and blood catheters.
Nearly 85% of the ICU patients were on antimicrobials in this study, higher than the 56.5%
and 77.3% reported in European and American ICUs, respectively [5,29]. Broad-spectrum
beta-lactam antibiotics (3rd, 4th generation cephalosporins and carbapenems) and fluoroquino-
lones accounted for 39.7% and 19.4% of total antimicrobials use in Vietnamese ICUs, respec-
tively. These proportions are higher than those reported by European ICUs of around 30% and
10% respectively [5]. Also combination therapy in our study is more common than in Euro-
pean ICUs: 62.5% versus 47.7% [5].
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Gram-negative bacteria were the most common cause of HAI, similar to studies in mainly
low and middle income countries [3,7,23]. Furthermore, the proportion of infection caused by
Acinetobacter in ICUs was highest in Asia (19.2%), which was more than five times in com-
pared with North America (3.7%) [30]. The two most frequently isolated bacteria were A. bau-
mannii and P. aeruginosa (accounted for 38.2% of total isolates), similar to a study in Turkey
in 2007–2008 (34.1% of isolates) [31]. Carbapenem resistance in A. baumannii, P. aeruginosa,
and K. pneumoniae in this study was higher than rates of 69.1%, 44.4% and 2.9%, respectively,
in Vietnam in 2007 and 2008 [25]. High prevalence of carbapenem resistance leads to an
increased colistin use [9] and emergence and spread of colistin resistance will follow. Antimi-
crobial stewardship programmes and the deployment of alternatives to carbapenems may help
to slow the development of further resistance to the remaining active antibiotics [32] and need
to be evaluated in this context. The high rates of MRSA and glycopeptide resistant enterococci
are also a major concern. However, the burden of Gram-positive infections as a cause of HAI is
relatively low as compared to Gram-negative infections.
A potential limitation of this study is the paucity of microbiology data for many HAIs due to
the few cultures taken in routine clinical care. However the microbiology results available repre-
sent valuable data for assessing the microorganisms causing HAIs and its susceptibility to antimi-
crobials in our setting. As HAIs had not previously been routinely surveyed in Vietnamese
hospitals, criteria for the diagnosis of specific HAI may not have been fully understood, poten-
tially leading to misclassification of specific HAIs. To limit this problem, we organized several
workshops and site visits to train doctors. The enrolment of patients who were just admitted to
ICU before 8.00 A.M. then were discharged from ICU soon after survey time could lead to under-
estimate the HAI prevalence. However, the mean ICU stays were much longer (4.8 to 16 days,
Table A in S1 File) means that number of these cases was not many and its impact on the HAI
prevalence was not significant. HAIs also are a sensitive issue in Vietnam; therefore ICU doctors
may not have reported all HAIs, leading to an underestimation. Tominimize this effect data, hos-
pitals were anonymized using codes. When data were uploaded we ran data checks and returned
queries to doctors that needed to be resolved. We therefore think that the hands-on supervision
and input from the study team ensured that data quality was optimal.
Conclusions
High prevalence of HAIs in Vietnamese ICUs, mainly caused by Gram-negative bacteria with
high rates of carbapenem resistance, and high levels of antimicrobial use illustrate the urgent
need for capacity strengthening in both rational antimicrobial use and infection control efforts
at national, regional and local levels.
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